[Membranoproliferative glomerulonephritis: Pathogenesis, pathophysiology and therapy].
Ohi
Hiroyuki
H
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001323:Autoantibodies; D003167:Complement Activation; D003178:Complement C3 Nephritic Factor; D003165:Complement System Proteins; D015432:Glomerulonephritis, Membranoproliferative / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D016174:Hepacivirus; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D014859:Warfarin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D001323:Autoantibodies; D003178:Complement C3 Nephritic Factor; C058872:complement 4 nephritic factor; D014859:Warfarin; D006493:Heparin; D003165:Complement System Proteins